Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 11, 2026

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

8.7K

Tissue Engineered Prevascularized Bone and Soft Tissue Flaps.

F Kurtis Kasper1, James Melville2, Jonathan Shum2

  • 1Department of Orthodontics, The University of Texas School of Dentistry, 7500 Cambridge Street, Suite 5130, Houston, TX 77054, USA.

Oral and Maxillofacial Surgery Clinics of North America
|November 29, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of postoperative pancreatic fistula (POPF) on long-term outcomes of patients who underwent pancreatic cancer resection: systematic review and meta-analysis.

Surgical oncology·2026
Same author

Tumor Implantation Site of Syngeneic Oral Cancer Models Differentially Induces Site-Dependent Local and Systemic Immunosuppression.

Cancers·2026
Same author

Exploring Spike-Dependent and ACE2-Independent SARS-CoV-2 Interactions with Salivary Epithelial Cells in the Absence of ACE2.

Biology·2026
Same author

Impact of Glucagon-like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors on Post-liver Transplant New-onset Major Adverse Cardiovascular Events, Graft Failure, Renal Outcome, and Mortality.

Transplantation direct·2026
Same author

Seasonal variation in immune-related adverse events in advanced cancer patients.

Cancer immunology, immunotherapy : CII·2026
Same author

Overuse of knee ultrasound in acute knee injury pathways in primary care: a quality improvement report.

Journal of primary health care·2026
Same journal

Principles and Outcomes of Compartmental Resection in Upper Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
Same journal

Anatomy and Spread of Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
Same journal

Gingivobuccal Cancers: Demographics and Geographic Variations.

Oral and maxillofacial surgery clinics of North America·2026
Same journal

Unilateral Cleft Lip: Primary Repair.

Oral and maxillofacial surgery clinics of North America·2026
Same journal

Advances in Reconstructive Surgery for Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
Same journal

Etiology and Pathogenesis of Gingivobuccal Cancers.

Oral and maxillofacial surgery clinics of North America·2026
See all related articles

The in vivo bioreactor strategy offers a promising alternative for maxillofacial reconstruction, creating patient-specific, prevascularized bone flaps. This approach combines tissue engineering with microvascular techniques for complex craniofacial defects.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Plastic Surgery

Background:

  • Maxillofacial reconstruction presents challenges due to complex craniofacial anatomy and limited soft tissue.
  • Traditional microvascular surgical techniques have limitations in addressing extensive defects.

Purpose of the Study:

  • To explore the in vivo bioreactor strategy as an alternative for maxillofacial reconstruction.
  • To discuss its potential for creating patient-specific, prevascularized bone flaps.

Main Methods:

  • Review of traditional vascularized bone flaps.
  • Analysis of preclinical studies on the in vivo bioreactor approach.
  • Examination of case reports utilizing this novel technique.

Main Results:

Keywords:
BioreactorsGrowth factorsMaxillofacial reconstructionMicrovascular surgeryPersonalized medicineTissue engineering

More Related Videos

Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor
10:56

Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor

Published on: August 1, 2022

3.4K
A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies
05:34

A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies

Published on: March 31, 2022

2.8K

Related Experiment Videos

Last Updated: Mar 11, 2026

Engineered Vascularized Muscle Flap
08:18

Engineered Vascularized Muscle Flap

Published on: January 11, 2016

8.7K
Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor
10:56

Procurement and Perfusion-Decellularization of Porcine Vascularized Flaps in a Customized Perfusion Bioreactor

Published on: August 1, 2022

3.4K
A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies
05:34

A Reliable Porcine Fascio-Cutaneous Flap Model for Vascularized Composite Allografts Bioengineering Studies

Published on: March 31, 2022

2.8K
  • The in vivo bioreactor strategy shows promise for generating prevascularized bone flaps.
  • This method integrates tissue engineering with microvascular reconstruction.
  • Patient-specific solutions for complex maxillofacial defects are being developed.

Conclusions:

  • The in vivo bioreactor strategy is a viable and promising approach for maxillofacial reconstruction.
  • Further research and clinical application are needed to overcome future challenges.
  • This technique holds potential for improving outcomes in reconstructive surgery.